1. Home
  2. OCAC vs HURA Comparison

OCAC vs HURA Comparison

Compare OCAC & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ocean Capital Acquisition Corporation Ordinary Shares

OCAC

Ocean Capital Acquisition Corporation Ordinary Shares

N/A

Current Price

$9.99

Market Cap

156.2M

Sector

Finance

ML Signal

N/A

Logo TuHURA Biosciences Inc.

HURA

TuHURA Biosciences Inc.

HOLD

Current Price

$2.16

Market Cap

160.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
OCAC
HURA
Founded
2021
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
156.2M
160.5M
IPO Year
2022
2010

Fundamental Metrics

Financial Performance
Metric
OCAC
HURA
Price
$9.99
$2.16
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $8.04
AVG Volume (30 Days)
36.3K
★ 250.0K
Earning Date
N/A
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 47.93
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.86
$0.41
52 Week High
$10.05
$3.43

Technical Indicators

Market Signals
Indicator
OCAC
HURA
Relative Strength Index (RSI) 66.51 59.70
Support Level $9.94 $2.06
Resistance Level N/A $2.22
Average True Range (ATR) 0.01 0.13
MACD -0.00 0.03
Stochastic Oscillator 33.33 92.86

Price Performance

Historical Comparison
OCAC
HURA

About OCAC Ocean Capital Acquisition Corporation Ordinary Shares

Ocean Capital Acquisition Corp is a blank check company.

About HURA TuHURA Biosciences Inc.

TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.

Share on Social Networks: